123 related articles for article (PubMed ID: 27020655)
1. Alterations of Cyclooxygenase-2 Methylation Levels Before and After Intervention Trial to Prevent Gastric Cancer in a Chinese Population.
Zhang Y; Zeng HM; Nie XR; Zhang L; Ma JL; Li JY; Pan KF; You WC
Cancer Prev Res (Phila); 2016 Jun; 9(6):484-90. PubMed ID: 27020655
[TBL] [Abstract][Full Text] [Related]
2. Helicobacter pylori, cyclooxygenase-2 and evolution of gastric lesions: results from an intervention trial in China.
Zhang Y; Pan KF; Zhang L; Ma JL; Zhou T; Li JY; Shen L; You WC
Carcinogenesis; 2015 Dec; 36(12):1572-9. PubMed ID: 26449252
[TBL] [Abstract][Full Text] [Related]
3. Effects of selective COX-2 inhibitor and Helicobacter pylori eradication on precancerous gastric lesions.
Wong BC; Zhang L; Ma JL; Pan KF; Li JY; Shen L; Liu WD; Feng GS; Zhang XD; Li J; Lu AP; Xia HH; Lam S; You WC
Gut; 2012 Jun; 61(6):812-8. PubMed ID: 21917649
[TBL] [Abstract][Full Text] [Related]
4. Anti-Helicobacter pylori therapy followed by celecoxib on progression of gastric precancerous lesions.
Zhang LJ; Wang SY; Huo XH; Zhu ZL; Chu JK; Ma JC; Cui DS; Gu P; Zhao ZR; Wang MW; Yu J
World J Gastroenterol; 2009 Jun; 15(22):2731-8. PubMed ID: 19522023
[TBL] [Abstract][Full Text] [Related]
5. Methylation status of COX-2 in blood leukocyte DNA and risk of gastric cancer in a high-risk Chinese population.
Su HJ; Zhang Y; Zhang L; Ma JL; Li JY; Pan KF; You WC
BMC Cancer; 2015 Dec; 15():979. PubMed ID: 26674784
[TBL] [Abstract][Full Text] [Related]
6. Helicobacter pylori infection, gastrin and cyclooxygenase-2 in gastric carcinogenesis.
Shao Y; Sun K; Xu W; Li XL; Shen H; Sun WH
World J Gastroenterol; 2014 Sep; 20(36):12860-73. PubMed ID: 25278683
[TBL] [Abstract][Full Text] [Related]
7. [Prophylactic effect of a selective COX-2 inhibitor celecoxib on carcinogen-induced gastric premalignant lesions in rats].
Tang BD; Zeng ZR; Hu PJ
Ai Zheng; 2006 Oct; 25(10):1205-9. PubMed ID: 17059761
[TBL] [Abstract][Full Text] [Related]
8. Promoter methylation of p16 associated with Helicobacter pylori infection in precancerous gastric lesions: a population-based study.
Dong CX; Deng DJ; Pan KF; Zhang L; Zhang Y; Zhou J; You WC
Int J Cancer; 2009 Jan; 124(2):434-9. PubMed ID: 18821580
[TBL] [Abstract][Full Text] [Related]
9. RUNX3 methylation and expression associated with advanced precancerous gastric lesions in a Chinese population.
Li WQ; Pan KF; Zhang Y; Dong CX; Zhang L; Ma JL; Zhou T; Li JY; You WC
Carcinogenesis; 2011 Mar; 32(3):406-10. PubMed ID: 21135153
[TBL] [Abstract][Full Text] [Related]
10. Short-term celecoxib intervention is a safe and effective chemopreventive for gastric carcinogenesis based on a Mongolian gerbil model.
Kuo CH; Hu HM; Tsai PY; Wu IC; Yang SF; Chang LL; Wang JY; Jan CM; Wang WM; Wu DC
World J Gastroenterol; 2009 Oct; 15(39):4907-14. PubMed ID: 19842220
[TBL] [Abstract][Full Text] [Related]
11. The selective cyclooxygenase-2 inhibitor nimesulide prevents Helicobacter pylori-associated gastric cancer development in a mouse model.
Nam KT; Hahm KB; Oh SY; Yeo M; Han SU; Ahn B; Kim YB; Kang JS; Jang DD; Yang KH; Kim DY
Clin Cancer Res; 2004 Dec; 10(23):8105-13. PubMed ID: 15585646
[TBL] [Abstract][Full Text] [Related]
12. Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-helicobacter pylori therapy.
Correa P; Fontham ET; Bravo JC; Bravo LE; Ruiz B; Zarama G; Realpe JL; Malcom GT; Li D; Johnson WD; Mera R
J Natl Cancer Inst; 2000 Dec; 92(23):1881-8. PubMed ID: 11106679
[TBL] [Abstract][Full Text] [Related]
13. Anti-LeY antibody enhances therapeutic efficacy of celecoxib against gastric cancer by downregulation of MAPKs/COX-2 signaling pathway: correlation with clinical study.
Aziz F; Yang X; Wang X; Yan Q
J Cancer Res Clin Oncol; 2015 Jul; 141(7):1221-35. PubMed ID: 25527419
[TBL] [Abstract][Full Text] [Related]
14. [The correlative analysis of indefinite dysplasia and dysplasia, and its p16 methylation in human gastric mucosa with Helicobacter pylori infection].
Dong CX; Deng da J; Zhou J; Zhang L; Ma JL; Pan KF; You WC
Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Jun; 40(3):280-4. PubMed ID: 18560456
[TBL] [Abstract][Full Text] [Related]
15. The Colombian Chemoprevention Trial: 20-Year Follow-Up of a Cohort of Patients With Gastric Precancerous Lesions.
Piazuelo MB; Bravo LE; Mera RM; Camargo MC; Bravo JC; Delgado AG; Washington MK; Rosero A; Garcia LS; Realpe JL; Cifuentes SP; Morgan DR; Peek RM; Correa P; Wilson KT
Gastroenterology; 2021 Mar; 160(4):1106-1117.e3. PubMed ID: 33220252
[TBL] [Abstract][Full Text] [Related]
16. Celecoxib inhibits apurinic/apyrimidinic endonuclease-1 expression and prevents gastric cancer in Helicobacter pylori-infected mongolian gerbils.
Futagami S; Kawagoe T; Horie A; Shindo T; Hamamoto T; Suzuki K; Kusunoki M; Miyake K; Gudis K; Tsukui T; Crowe SE; Sakamoto C
Digestion; 2008; 78(2-3):93-102. PubMed ID: 18987470
[TBL] [Abstract][Full Text] [Related]
17. [Association between promoter methylation of cyclooxygenase-2 and expression, and precancerous gastric lesions in a high-risk population].
Nie XR; Zhang Y; Pan KF; Zhang L; Zhou T; Li JY; You WC
Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Jul; 43(7):571-5. PubMed ID: 19954066
[TBL] [Abstract][Full Text] [Related]
18. Celecoxib inhibits Cdx2 expression and prevents gastric cancer in Helicobacter pylori-infected Mongolian gerbils.
Futagami S; Suzuki K; Hiratsuka T; Shindo T; Hamamoto T; Tatsuguchi A; Ueki N; Shinji Y; Kusunoki M; Wada K; Miyake K; Gudis K; Tsukui T; Sakamoto C
Digestion; 2006; 74(3-4):187-98. PubMed ID: 17341852
[TBL] [Abstract][Full Text] [Related]
19. DNA Methylation Predicts Progression of Human Gastric Lesions.
Schneider BG; Mera R; Piazuelo MB; Bravo JC; Zabaleta J; Delgado AG; Bravo LE; Wilson KT; El-Rifai W; Peek RM; Correa P
Cancer Epidemiol Biomarkers Prev; 2015 Oct; 24(10):1607-13. PubMed ID: 26269563
[TBL] [Abstract][Full Text] [Related]
20. Methylation and Expression of Nonclustered Protocadherins Encoding Genes and Risk of Precancerous Gastric Lesions in a High-Risk Population.
Wu S; Zhang Y; Zhang L; Ma JL; Zhou T; Li ZX; Liu WD; Li WQ; You WC; Pan KF
Cancer Prev Res (Phila); 2018 Nov; 11(11):717-726. PubMed ID: 30213786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]